Accelmed Partners II L.P. - Nov 21, 2022 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
10%+ Owner
Signature
/s/ Uri Geiger, Managing Partner
Stock symbol
NPCE
Transactions as of
Nov 21, 2022
Transactions value $
$585,046
Form type
4
Date filed
11/23/2022, 04:29 PM
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Purchase $492K +328K +8.11% $1.50 4.37M Nov 21, 2022 Direct F1
transaction NPCE Common Stock Purchase $93.5K +62.4K +1.43% $1.50 4.43M Nov 22, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.